Di Xie

4.5k total citations · 1 hit paper
84 papers, 2.8k citations indexed

About

Di Xie is a scholar working on Nephrology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Di Xie has authored 84 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Nephrology, 19 papers in Molecular Biology and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Di Xie's work include Chronic Kidney Disease and Diabetes (19 papers), Renal Diseases and Glomerulopathies (9 papers) and Advanced Glycation End Products research (7 papers). Di Xie is often cited by papers focused on Chronic Kidney Disease and Diabetes (19 papers), Renal Diseases and Glomerulopathies (9 papers) and Advanced Glycation End Products research (7 papers). Di Xie collaborates with scholars based in China, United States and Japan. Di Xie's co-authors include Fan Fan Hou, Guo Bao Wang, Jian Jiang, Min Liang, Zhi Guo, Xun Zhang, Guo Hua Zhang, Xun Zhang, Xun Zhang and Zhan Zhou and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Scientific Reports.

In The Last Decade

Di Xie

80 papers receiving 2.7k citations

Hit Papers

Efficacy and Safety of Benazepril for Advanced Chronic Re... 2006 2026 2012 2019 2006 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Di Xie China 28 952 670 555 434 350 84 2.8k
Sang Youb Han South Korea 33 916 1.0× 545 0.8× 982 1.8× 718 1.7× 203 0.6× 115 3.3k
Maria Luiza Caramori United States 16 1.3k 1.4× 395 0.6× 555 1.0× 852 2.0× 345 1.0× 32 2.7k
Chagriya Kitiyakara Thailand 23 1.2k 1.3× 546 0.8× 542 1.0× 347 0.8× 100 0.3× 84 2.7k
Fuyuhiko Nishijima Japan 32 1.2k 1.2× 289 0.4× 780 1.4× 266 0.6× 202 0.6× 37 2.4k
Anna Gluba-Brzózka Poland 29 677 0.7× 541 0.8× 692 1.2× 496 1.1× 115 0.3× 89 3.0k
Anil Bhanudas Gaikwad India 29 516 0.5× 372 0.6× 908 1.6× 376 0.9× 176 0.5× 110 2.3k
Stefanos Roumeliotis Greece 22 927 1.0× 277 0.4× 320 0.6× 273 0.6× 137 0.4× 103 2.2k
Sungjin Chung South Korea 30 658 0.7× 267 0.4× 792 1.4× 401 0.9× 142 0.4× 100 2.5k
Seok Joon Shin South Korea 28 649 0.7× 332 0.5× 738 1.3× 389 0.9× 100 0.3× 89 2.6k
Mehdi Nematbakhsh Iran 29 496 0.5× 451 0.7× 493 0.9× 396 0.9× 97 0.3× 172 2.9k

Countries citing papers authored by Di Xie

Since Specialization
Citations

This map shows the geographic impact of Di Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Xie more than expected).

Fields of papers citing papers by Di Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Xie. The network helps show where Di Xie may publish in the future.

Co-authorship network of co-authors of Di Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Di Xie. A scholar is included among the top collaborators of Di Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Xie. Di Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Tao & Di Xie. (2025). Exploring the path for patient organizations to participate in medical security for rare diseases. Frontiers in Public Health. 13. 1484286–1484286.
3.
Xie, Di, et al.. (2024). Hyperbaric oxygen therapy promotes the browning of white fat and contributes to the healing of diabetic wounds. International Wound Journal. 21(4). e14867–e14867. 5 indexed citations
5.
Hou, Fan Fan, Di Xie, Jun Wang, et al.. (2023). Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy. JAMA Network Open. 6(2). e2254054–e2254054. 62 indexed citations
6.
Zhang, Yuanyuan, Panpan He, Guobao Wang, et al.. (2022). Interaction of Serum Alkaline Phosphatase and Folic Acid Treatment on Chronic Kidney Disease Progression in Treated Hypertensive Adults. Frontiers in Pharmacology. 12. 753803–753803. 5 indexed citations
7.
Li, Huan, Panpan He, Yuanyuan Zhang, et al.. (2021). Self-Perceived Psychological Stress and Risk of First Stroke in Treated Hypertensive Patients. Psychosomatic Medicine. 84(2). 237–243. 3 indexed citations
8.
Xie, Di, Hao Zhao, Xin Xu, et al.. (2021). Intensity of Macrophage Infiltration in Glomeruli Predicts Response to Immunosuppressive Therapy in Patients with IgA Nephropathy. Journal of the American Society of Nephrology. 32(12). 3187–3196. 31 indexed citations
9.
Zhu, Yajie, et al.. (2021). Clinical Strains of Pseudomonas aeruginosa Secrete LasB Elastase to Induce Hemorrhagic Diffuse Alveolar Damage in Mice. Journal of Inflammation Research. Volume 14. 3767–3780. 8 indexed citations
10.
Liu, Mengyi, Chun Zhou, Zhuxian Zhang, et al.. (2020). Relationship of visceral adiposity index with new-onset proteinuria in hypertensive patients. Clinical Nutrition. 40(2). 438–444. 10 indexed citations
11.
Xie, Di, Xiaoli Ge, Yanli Ma, et al.. (2020). Clemastine improves hypomyelination in rats with hypoxic–ischemic brain injury by reducing microglia-derived IL-1β via P38 signaling pathway. Journal of Neuroinflammation. 17(1). 57–57. 41 indexed citations
12.
Yang, Xiaobing, Hong Zhang, Xin Xu, et al.. (2019). Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression. American Journal of Kidney Diseases. 75(3). 384–393. 37 indexed citations
13.
Qin, Xianhui, Youbao Li, Hui Yuan, et al.. (2015). Relationship of MTHFR Gene 677C→T Polymorphism, Homocysteine, and Estimated Glomerular Filtration Rate Levels With the Risk of New-Onset Diabetes. Medicine. 94(7). e563–e563. 11 indexed citations
14.
Qin, Xianhui, Yuejuan Wang, Youbao Li, et al.. (2015). Risk factors for renal function decline in adults with normal kidney function: a 7-year cohort study. Journal of Epidemiology & Community Health. 69(8). 782–788. 22 indexed citations
15.
Li, Yanmin, Xianhui Qin, Di Xie, et al.. (2014). Body mass index and annual estimated GFR decline in Chinese adults with normal renal function. European Journal of Clinical Nutrition. 69(8). 922–926. 7 indexed citations
16.
Liu, Jun, Guoliang Zhang, Li Li, et al.. (2014). Therapeutic Effect of Jinzhen Oral Liquid for Hand Foot and Mouth Disease: A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Trial. PLoS ONE. 9(4). e94466–e94466. 10 indexed citations
17.
Zhou, Qiugen, Shengjie Wu, Jianwei Tian, et al.. (2012). Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients. Nephrology. 17(7). 642–649. 37 indexed citations
18.
Jiang, Shiqin, Jia Jia, Yuanyuan Shang, et al.. (2010). Selected Abstracts Submitted to the 2nd International Cancer Fatigue Symposium: Putting the Pieces Together. Current Oncology. 17(5). 78–83. 1 indexed citations
19.
He, Li, Min Liang, Fan Fan Hou, et al.. (2008). Ethanol extraction of Picrorhiza scrophulariiflora prevents renal injury in experimental diabetes via anti-inflammation action. Journal of Endocrinology. 200(3). 347–355. 37 indexed citations
20.
Liu, Zhengrong, et al.. (2006). [Clinical significance of antineutrophil cytoplasmic antibodies in patients with lupus nephritis].. PubMed. 26(6). 833–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026